SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950144-05-008566
Filing Date
2005-08-10
Accepted
2005-08-10 17:17:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 EARNEST PARTNERS, LLC/KV PHARMACEUTICAL COMPANY g96870asc13gza.htm SC 13G/A 31252
  Complete submission text file 0000950144-05-008566.txt   33104
Mailing Address 2503 S HANLEY RD ST LOUIS MO 63144
Business Address 2503 S HANLEY RD ST LOUIS MO 63144 3146456600
KV PHARMACEUTICAL CO /DE/ (Subject) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-12338 | Film No.: 051014298
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 FOURTEENTH STREET, SUITE 2300 ATLANTA GA 30309
Business Address 75 FOURTEENTH STREET, SUITE 2300 ATLANTA GA 30309 4048158772
EARNEST PARTNERS LLC (Filed by) CIK: 0001102578 (see all company filings)

IRS No.: 582386669 | State of Incorp.: GA | Fiscal Year End: 1231
Type: SC 13G/A